How CBD Fights Cancer Cells: A Review of the Molecular Mechanisms
CBD shows anti-cancer properties through multiple molecular pathways including receptor-dependent and independent mechanisms that trigger cancer cell death.
Quick Facts
What This Study Found
CBD inhibits tumor growth, reduces inflammation, and induces autophagy and apoptosis. Effects can be receptor-dependent (CB1, CB2, TRPV, PPARs) or receptor-independent (ceramide biosynthesis, ER stress). Mechanisms vary by cancer type.
Key Numbers
CBD acts through CB1, CB2, TRPV, and PPAR receptors. Receptor-independent mechanisms include ceramide biosynthesis and ER stress induction.
How They Did This
Narrative review examining recent evidence on CBD anti-cancer activity across different cancer types, focusing on cellular and molecular mechanisms.
Why This Research Matters
Understanding how CBD kills cancer cells at the molecular level is essential for developing it into a legitimate therapeutic rather than relying on anecdotal claims.
The Bigger Picture
CBD is already used for chemotherapy side effects. If direct anti-cancer mechanisms are validated clinically, it could transition from supportive care to active treatment.
What This Study Doesn't Tell Us
Most evidence from cell culture and animal studies. Clinical trial data extremely limited. Optimal dosing unknown.
Questions This Raises
- ?Which cancer types are most responsive to CBD?
- ?Can CBD enhance existing chemotherapy?
Trust & Context
- Key Stat:
- CBD acts through at least 4 receptor types and multiple independent pathways to kill cancer cells
- Evidence Grade:
- Review of primarily preclinical data with very limited clinical evidence.
- Study Age:
- Published in 2024.
- Original Title:
- Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective.
- Published In:
- International journal of molecular sciences, 25(11) (2024)
- Database ID:
- RTHC-05524
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can CBD treat cancer?
Lab studies show CBD can kill cancer cells through multiple mechanisms, but very limited clinical evidence from human trials exists.
How does CBD fight cancer?
Through both receptor-dependent (CB1, CB2, TRPV, PPARs) and receptor-independent mechanisms involving ceramide and ER stress.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05524APA
Mashabela, Manamele Dannies; Kappo, Abidemi Paul. (2024). Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective.. International journal of molecular sciences, 25(11). https://doi.org/10.3390/ijms25115659
MLA
Mashabela, Manamele Dannies, et al. "Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective.." International journal of molecular sciences, 2024. https://doi.org/10.3390/ijms25115659
RethinkTHC
RethinkTHC Research Database. "Anti-Cancer and Anti-Proliferative Potential of Cannabidiol:..." RTHC-05524. Retrieved from https://rethinkthc.com/research/mashabela-2024-anticancer-and-antiproliferative-potential
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.